27 related articles for article (PubMed ID: 2802753)
1. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.
Colomer R; Ruibal A; Genollá J; Rubio D; Del Campo JM; Bodi R; Salvador L
Breast Cancer Res Treat; 1989 Mar; 13(2):123-33. PubMed ID: 2730960
[TBL] [Abstract][Full Text] [Related]
2. Markers in breast cancer: does CEA add to the detection by CA 15.3?
Delarue JC; Mouriesse H; Dubois F; Friedman S; May-Levin F
Breast Cancer Res Treat; 1988 Jul; 11(3):273-6. PubMed ID: 3167234
[TBL] [Abstract][Full Text] [Related]
3. [CA 15-3 and CEA as tumor markers in the diagnosis of the recurrence of breast cancer].
Engel K; Schmid H; Hanke J; Kaufmann M; Müller A
Geburtshilfe Frauenheilkd; 1988 May; 48(5):309-12. PubMed ID: 3165077
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
5. [Is follow-up of breast cancer with CEA and CA 15-3 justified?].
Fritsche E; Benz J
Helv Chir Acta; 1992 May; 59(1):225-9. PubMed ID: 1526832
[TBL] [Abstract][Full Text] [Related]
6. [The value of tumor markers CA 15-3 and CEA in breast cancer].
Buck I; Lindner C; Böge K; Kitschke HJ
Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
[TBL] [Abstract][Full Text] [Related]
7. [Tumor markers of breast cancer].
Sławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2004 Jul; 58():292-300. PubMed ID: 15280799
[TBL] [Abstract][Full Text] [Related]
8. The importance of CA 72-4 and CA 19-9 dosing in gastric cancer.
Roșu MC; Ardelean A; Moldovan SD; Faur FI; Nesiu A; Totoloci BD
J Med Life; 2023 Feb; 16(2):186-188. PubMed ID: 36937484
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers for breast cancer.
Hayes DF
Ann Oncol; 1993 Dec; 4(10):807-19. PubMed ID: 8117599
[TBL] [Abstract][Full Text] [Related]
10. The role of tumour markers in ovarian cancer.
Gargano G; Correale M; Abbate I; Falco G; De Frenza N; Lorusso V; De Lena M; De Leonardis A
Clin Exp Obstet Gynecol; 1990; 17(1):23-9. PubMed ID: 2194706
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biochemical markers in colorectal cancer.
McDermott U; Longley DB; Johnston PG
Ann Oncol; 2002; 13 Suppl 4():235-45. PubMed ID: 12401696
[No Abstract] [Full Text] [Related]
12. Breast cancer follow-up in the adjuvant setting.
Khatcheressian J; Swainey C
Curr Oncol Rep; 2008 Jan; 10(1):38-46. PubMed ID: 18366959
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
